MD
Medartis Holding AG
MDRSF · OTC
$115.00 +0.00% (+$0.00)
Market Cap CHF 1.19B
P/E Ratio 142.39x
Div. Yield -
ROE 3.07%
Bulios Fair Price
$157.86
37.3% upside
Current Price
$115
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MDRSF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
17 /100
Expensive EV/EBITDA 28.73x
P/S 4.42x
P/B 4.31x
Growth
75 /100
Growing Book val. growth 5.08%
Rev. growth 13.77%
FCF growth N/A
Profitability
35 /100
Moderate Net margin 3.10%
Op. margin 0.72%
FCF margin 3.47%
Quality
12 /100
Poor ROE 3.07%
ROA 1.49%
Asset turnover 0.48x
Debt
61 /100
Moderate Current ratio 2.21x
Int. coverage 2.71x
Net debt/EBITDA 2.73x
Stability
54 /100
Moderate Rev. volatility 7.08%
EPS volatility 163.28%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MDRSF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Matthias Schupp
Employees
1,337
Headquarters
Basel
Upcoming events
02 MAR
Earnings
Upcoming earnings report